Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study

December 2025 in “ Cureus ”

Md. Shihab Talukder, A.T.M. Asaduzzaman, Mohammad Abul Kalam Azad, Mohammad Jamal Uddin, Pranam Swapan Dash, Wasi Deen Ahmed

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on cureus.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study

April 2023 in “The Egyptian Journal of Hospital Medicine”

Higher Interleukin 17A levels may indicate more severe alopecia areata.

Increased Serum Interleukin-17A Levels Correlate with Disease Severity and Poor Prognostic Factors in Patients with Alopecia Areata

research Increased Serum Interleukin-17A Levels Correlate with Disease Severity and Poor Prognostic Factors in Patients with Alopecia Areata

October 2021 in “Dermatology Reports”

Higher IL-17A levels indicate more severe alopecia areata.

research Alopecia Areata Update

391 citations , January 2010 in “Journal of The American Academy of Dermatology”

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.